(Q41918910)

14 October 2017

title

Hydroxychloroquine reduces risk of incident diabetes mellitus in lupus patients in a dose-dependent manner: a population-based cohort study (English)

1 reference

14 October 2017

1 reference

Yi-Ming Chen

1

1 reference

14 October 2017

Ching-Heng Lin

2

1 reference

14 October 2017

Tsuo-Hung Lan

3

1 reference

14 October 2017

Hsin-Hua Chen

4

1 reference

14 October 2017

Shih-Ni Chang

5

1 reference

14 October 2017

Yi-Hsing Chen

6

1 reference

14 October 2017

Jun-Sing Wang

7

1 reference

14 October 2017

Wei-Ting Hung

8

1 reference

14 October 2017

Joung-Liang Lan

9

1 reference

14 October 2017

Der-Yuan Chen

10

1 reference

14 October 2017

publication date

12 January 2015

1 reference

14 October 2017

1 reference

14 October 2017

volume

54

1 reference

14 October 2017

issue

7

1 reference

14 October 2017

page(s)

1244-1249

1 reference

Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus

14 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU451

'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU451

Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU451

Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU451

Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU451

Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU451

Hypoglycaemia induced by hydroxychloroquine in a non-diabetic patient treated for RA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU451

The effectiveness of hydroxychloroquine in patients with type 2 diabetes mellitus who are refractory to sulfonylureas--a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU451

Changes in glycosylated hemoglobin after initiation of hydroxychloroquine or methotrexate treatment in diabetes patients with rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU451

Hydroxychloroquine and glycemia in women with rheumatoid arthritis and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU451

Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU451

Diabetes management in special situations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU451

Diabetes mellitus complicating systemic lupus erythematosus - analysis of the UCL lupus cohort and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU451

Type 2 diabetes as an inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU451

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU451

Elevated levels of the anti-inflammatory interleukin-1 receptor antagonist precede the onset of type 2 diabetes: the Whitehall II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU451

The prevalence and management of hyperglycaemia in patients with rheumatoid arthritis on corticosteroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU451

Glucocorticoid-induced diabetes mellitus in patients with systemic lupus erythematosus treated with high-dose glucocorticoid therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU451

Comparison of self-reported and medical record health care utilization measures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU451

10.1093/RHEUMATOLOGY/KEU451

21 January 2018

Identifiers

DOI

1 reference

14 October 2017

1 reference